| 產品名稱 | Cryptococcus neoformans (Sanfelice) Vuillemin |
|---|---|
| 商品貨號 | B198648 |
| Deposited As | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
| Strain Designations | 98 |
| Alternate State | Filobasidiella neoformans Kwon-Chung |
| Application | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format | freeze-dried |
| Type Strain | no |
| Antigenic Properties | serotype A
Ref  Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 |
| Preceptrol® | no |
| Comments | medium capsule |
| Medium | ATCC® Medium 28: Emmons' modification of Sabouraud's agar |
| Growth Conditions | Temperature: 37.0°C |
| Name of Depositor | TG Mitchell |
| Chain of Custody | ATCC <<--TG Mitchell<<--J. Simon |
| Isolation | bovine supramammary lymph node |
| References | Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
